Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Consolidated Diluted EPS At -0.6684

0

For the year ended 2015-08-31 Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) basic consolidated EPS came $-0.6684. Furthermore, for the quarter closed 2015-08-31, it was $-0.6684.

Consolidated diluted EPS

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) consolidated diluted EPS was -0.6684 for the year ended 2015-08-31. For the quarter ended 2015-08-31, it stood at $-0.6684.

EPS contribution from parent

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) basic EPS was $-0.6684 for the year ended 2015-08-31 from its parent entity. It was $-0.6684 for the quarter closed 2015-08-31.

EPS from continuing operations

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) EPS from continuing activities was $-0.6684 for the fiscal ended 2015-08-31. For the quarter ended 2015-08-31, this figure was $-0.6684.

Basic net EPS

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) basic net EPS was $-0.67 for the year ended 2015-08-31. For the quarter ended 2015-08-31, it came at $-0.67.

Diluted EPS from parent

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) diluted EPS from parent entity came at $-0.6684 for the year ended 2015-08-31. For the quarter ended 2015-08-31 it was $-0.6684.

Net diluted EPS

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) net diluted EPS was $-0.67 for the fiscal closed 2015-08-31. For the quarter ended 2015-08-31, net diluted EPS was $-0.67.

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) net basic EPS was $-0.67 for the year ended 2015-08-31. For the quarter ended 2015-08-31, it was $-0.67.

Basic diluted EPS

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) basic diluted EPS was $-0.1521 for the quarter ended 2015-08-31. For the year ended 2015-08-31, basic diluted EPS was $-0.1521.

For the year ended 2015-08-31, basic shares outstanding were 10.821 while for the quarter ended 2015-08-31 is 10.821.

For the fiscal ended 2015-08-31, the diluted outstanding shares were 10.821 and for the quarter ended 2015-08-31 it was 10.821. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 17 times, 1 visits today)